Periodontal Status and Pregnancy or Delivery Complications in Type 1 Diabetes Mellitus Pregnant Women

August 21, 2023 updated by: University of Ljubljana

Periodontal Status and Pregnancy or Delivery Complications in Type 1 Diabetes Mellitus Pregnant Women: a Case-control Study From Slovenia

The results of contemporary studies suggest an association between inflammatory periodontal disease and pregnancy and delivery complications. The aim of this study was to assess the association between periodontal disease, clinical periodontal parameters and pregnancy or delivery complications in type 1 diabetes mellitus and non-diabetic pregnant women.

Study Overview

Detailed Description

The results of contemporary studies suggest an association between inflammatory periodontal disease and pregnancy and delivery complications. The aim of this study was to assess the association between periodontal disease, clinical periodontal parameters and pregnancy or delivery complications in type 1 diabetes mellitus and non-diabetic pregnant women. Methods: 15 type 1 diabetes mellitus and 15 non-diabetic primiparous women were enrolled in the prospective "case-control" study. Investigators compared periodontal status, levels of glycosylated haemoglobin (HbA1c), high sensitivity C-Reactive Protein (hs-CRP), gestational week of birth, birth weight of a newborn and pregnancy or delivery complications (C-section, pre-eclampsia) between the groups.

Study Type

Observational

Enrollment (Actual)

30

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Pregnant women included in study entitled: Periodontal status of type 1 diabetes mellitus and healthy pregnant women: a case-control study from Slovenia

Description

Inclusion Criteria:

  • Healthy Pregnant Women
  • Pregnant Women with Diabetes Mellitus type 1
  • Healthy Pregnant Women with signs of Periodontal Disease
  • Pregnant Women with Diabetes Mellitus type 1 and signs of Periodontal disease

Exclusion Criteria:

  • Smokers
  • Former smokers who had stopped smoking less than five years before participation
  • Pregnant women with other systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control Group
Healthy pregnant women
Analysis of post-delivery reports for pregnancy and/or delivery complications.
Measuring clinical periodontal parameters for assessing presence of periodontal disease.
Case Group
Pregnant women with Diabetes Mellitus Type 1
Analysis of post-delivery reports for pregnancy and/or delivery complications.
Measuring clinical periodontal parameters for assessing presence of periodontal disease.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GWOB - Gestational week of birth
Time Frame: Day of delivery
Week number
Day of delivery
Birth weight
Time Frame: Day of delivery
Weight in kg
Day of delivery
Number of Delivery and/or Pregnancy complications
Time Frame: Day of delivery
Yes/No
Day of delivery
Number of C-section
Time Frame: Day of delivery
Yes/No
Day of delivery
Number of pregnant women with Pre-eclampsia
Time Frame: Between 28th and 34th week of gestation
Yes/No
Between 28th and 34th week of gestation
Number of Pre-term births GWOB (Gestational week of birth) ≤ 37th week
Time Frame: Day of delivery
Yes/No
Day of delivery
number of Births with weight ≤ 2500 g
Time Frame: Day of delivery
Yes/No
Day of delivery
Number of pregnant women with Periodontal disease
Time Frame: Between 28th and 34th week of gestation
Yes/No
Between 28th and 34th week of gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Between 28th and 34th week of gestation
Age
Between 28th and 34th week of gestation
BMI (Body mass index)
Time Frame: Between 28th and 34th week of gestation
Body mass index - measure of body fat based on height and weight (BMI = Weight (kg) / Height (m)²)
Between 28th and 34th week of gestation
PPD (Probing pocket depth)
Time Frame: Between 28th and 34th week of gestation
Probing pocket depth (measured on 6 sites around teeth, unit: mm)
Between 28th and 34th week of gestation
CAL (Clinical attachment loss)
Time Frame: Between 28th and 34th week of gestation
Clinical attachment loss (measured on 6 sites around teeth, unit: mm) - This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ). Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ.
Between 28th and 34th week of gestation
TPIB (Total periodontal inflammatory burden)
Time Frame: Between 28th and 34th week of gestation
Total periodontal inflammatory burden - measures of average teeth neck circumferences by tooth type, probing depth (PD) and bleeding on probing (BOP). The subgingival area for each tooth was calculated by multiplying 1/6th of the average cervical circumference of the tooth with each of the six measurements of probing depth. The sum of subgingival areas of all present teeth in a subject represented the total subgingival area of an individual.
Between 28th and 34th week of gestation
percantage of sites with BOP (Bleeding on probing)
Time Frame: Between 28th and 34th week of gestation
Bleeding on probing, Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: %
Between 28th and 34th week of gestation
TBPW area (Total bleeding periodontal wound)
Time Frame: Between 28th and 34th week of gestation
Total bleeding periodontal wound - measures of average teeth neck circumferences by tooth type, probing depth (PD) and bleeding on probing (BOP). The subgingival area for each tooth was calculated by multiplying 1/6th of the average cervical circumference of the tooth with each of the six measurements of probing depth. The sum of subgingival bleeding areas of all present teeth in a subject represented the total subgingival area of an individual.
Between 28th and 34th week of gestation
Percantage of HbA1C (Glycosylated haemoglobin)
Time Frame: Between 28th and 34th week of gestation
Glycosylated haemoglobin, Unit: %
Between 28th and 34th week of gestation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Rok Schara, DMD, PhD, Assistant Professor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2012

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

May 8, 2023

First Submitted That Met QC Criteria

August 16, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

August 24, 2023

Last Update Submitted That Met QC Criteria

August 21, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All Research data will be available or shared on individual request. Example: conducting Meta-Analysis.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 1

Clinical Trials on Pregnancy and/or delivery complications

3
Subscribe